Diallyl Trisulfide Enhances the Survival of Multiterritory Perforator Skin Flaps

The multiterritory perforator flap is one of the widest flap patterns used to repair tissue defects. However, flap necrosis of the distal part is still a challenging issue for plastic surgeons. Diallyl trisulfide (DATS) is an efficient ingredient extracted from garlic, exerting many important effect...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology Vol. 13; p. 809034
Main Authors: Dong, Chengji, Chen, Zhuliu, Zhu, Linxin, Bsoul, Najeeb, Wu, Hongqiang, Jiang, Jingtao, Chen, Xuankuai, Lai, Yingying, Yu, Gaoxiang, Gu, Yanlan, Guo, Xiaoshan, Gao, Weiyang
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 15-02-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The multiterritory perforator flap is one of the widest flap patterns used to repair tissue defects. However, flap necrosis of the distal part is still a challenging issue for plastic surgeons. Diallyl trisulfide (DATS) is an efficient ingredient extracted from garlic, exerting many important effects on different diseases. Our experiment aims to reveal whether DATS has a beneficial effect on the survival of perforator flaps and to explore its mechanism of action. The results showed that DATS enhanced angiogenesis and autophagy and reduced cell apoptosis and oxidative stress, thereby improving the survival rate of skin flaps. After co-administration with autophagy inhibitor 3-methyladenine (3MA), perforator flap survival was further improved. Mechanistically, we showed that PI3K/Akt and AMPK-HIF-1α signaling pathways in flap were activated under DATS treatment. All in all, DATS promoted the survival of multiterritory perforator flaps the synergistic regulation of PI3K/Akt and AMPK-HIF-1α signaling pathways, and inhibition of DATS-induced autophagy further improves flap survival.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Nevena Jeremic, University of Kragujevac, Serbia
Edited by: Apostolos Zarros, University of Glasgow, United Kingdom
These authors have contributed equally to this work.
Sheikh Umar Ahmad, Indian Institute of Integrative Medicine (CSIR), India
Lulu Jiang, Boston University, United States
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2022.809034